Department of Urology, Addenbrookes Hospital, Hills Road, Cambridge CB2 0XZ, UK.
Br J Cancer. 2012 Jan 31;106(3):436-9. doi: 10.1038/bjc.2011.596. Epub 2012 Jan 12.
Prostate cancer in the United Kingdom is mainly diagnosed from primary care referrals based on national guidelines published by the Department of Health. Here we investigated the characteristics of cancers detected through the use of these guidelines.
A prospective two-centre study was established to assess men referred from the primary care based on the UK national guidelines.
The overall cancer detection rate was 43% (169 out of 397) with 15% (26 out of 169) of all cancers metastatic at presentation. Amongst 50-69-year-old men these rates were 34% (68 out of 200) and 15% (10 out of 68). Only 21% (25 out of 123) of men with local cancers had low-risk disease. In comparison to a historical cohort from 2001 (n=137) we found no overall differences in rates of metastatic disease, locally advanced tumours, or risk categories. Amongst 50-69-year-old men with local disease, however, we observed an increase in detection of low-risk cancers in a contemporary cohort (P=0.04). This was primarily because of the increased detection of low-stage organ-confined tumours in this group (P=0.02).
Use of the UK prostate cancer guidelines detects a high proportion of clinically significant cancers. Use of the guidelines does not seem to have led to an overall change in the clinical characteristics of presenting cancers. There may, however, be a specific benefit in detecting more low-risk disease in younger men.
英国的前列腺癌主要根据卫生部发布的国家指南,从初级保健转介中诊断出来。在此,我们研究了通过使用这些指南检测到的癌症的特征。
建立了一项前瞻性的双中心研究,以评估根据英国国家指南从初级保健转介的男性。
总体癌症检出率为 43%(169 例中有 169 例),所有癌症中有 15%(26 例中有 169 例)在就诊时已转移。在 50-69 岁的男性中,这些比例为 34%(200 例中有 68 例)和 15%(68 例中有 10 例)。只有 21%(123 例中有 25 例)的局部癌症患者患有低危疾病。与 2001 年的历史队列(n=137)相比,我们没有发现转移性疾病、局部晚期肿瘤或风险类别方面的总体差异。然而,在患有局部疾病的 50-69 岁男性中,我们观察到当代队列中低危癌症的检出率有所增加(P=0.04)。这主要是因为该组中低分期的器官局限肿瘤的检出率增加(P=0.02)。
使用英国前列腺癌指南可以检测到很大比例的具有临床意义的癌症。使用这些指南似乎并没有导致就诊癌症的临床特征发生总体变化。然而,在年轻男性中,可能有特定的益处可以检测到更多的低危疾病。